| Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data F Finotello, C Mayer, C Plattner, G Laschober, D Rieder, H Hackl, ... Genome medicine 11, 1-20, 2019 | 879 | 2019 |
| Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors T Duhen, R Duhen, R Montler, J Moses, T Moudgil, NF De Miranda, ... Nature communications 9 (1), 2724, 2018 | 712 | 2018 |
| Neoantigen landscape dynamics during human melanoma–T cell interactions EME Verdegaal, NFCC De Miranda, M Visser, T Harryvan, ... Nature 536 (7614), 91-95, 2016 | 470 | 2016 |
| Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas K Georgiou, L Chen, M Berglund, W Ren, NFCC de Miranda, S Lisboa, ... Blood 127 (24), 3026-3034, 2016 | 213 | 2016 |
| Cancer immunotherapy: broadening the scope of targetable tumours J van den Bulk, EME Verdegaal, NFCC de Miranda Open biology 8 (6), 180037, 2018 | 207 | 2018 |
| The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers LL Kodach, E Wiercinska, NFCC De Miranda, SA Bleuming, AR Musler, ... Gastroenterology 134 (5), 1332-1341. e3, 2008 | 204 | 2008 |
| Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I–II colon cancer patients WE Mesker, GJ Liefers, J Junggeburt, GW van Pelt, P Alberici, ... Analytical Cellular Pathology 31 (3), 169-178, 2009 | 182 | 2009 |
| Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype JE Grolleman, RM De Voer, FA Elsayed, M Nielsen, RDA Weren, C Palles, ... Cancer cell 35 (2), 256-266. e5, 2019 | 157 | 2019 |
| Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations C Wu, NFCC de Miranda, L Chen, AM Wasik, L Mansouri, W Jurczak, ... Oncotarget 7 (25), 38180, 2016 | 147 | 2016 |
| Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients NFCC de Miranda, K Georgiou, L Chen, C Wu, Z Gao, A Zaravinos, ... Blood 124 (16), 2544-2553, 2014 | 134 | 2014 |
| Memory CD4+ T cells are generated in the human fetal intestine N Li, V van Unen, T Abdelaal, N Guo, SA Kasatskaya, K Ladell, ... Nature immunology 20 (3), 301-312, 2019 | 127 | 2019 |
| A 40-marker panel for high dimensional characterization of cancer immune microenvironments by imaging mass cytometry ME Ijsselsteijn, R van der Breggen, A Farina Sarasqueta, F Koning, ... Frontiers in immunology 10, 484562, 2019 | 125 | 2019 |
| Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment YM Schrage, IH Briaire-de Bruijn, NFCC de Miranda, J van Oosterwijk, ... Cancer Research 69 (15), 6216-6222, 2009 | 121 | 2009 |
| HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression JWF Dierssen, NFCC de Miranda, S Ferrone, M van Puijenbroek, ... BMC cancer 7, 1-11, 2007 | 119 | 2007 |
| High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity NL De Vries, V Van Unen, ME Ijsselsteijn, T Abdelaal, R Van Der Breggen, ... Gut 69 (4), 691-703, 2020 | 115 | 2020 |
| Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype M Kostine, AHG Cleven, NFCC de Miranda, A Italiano, AM Cleton-Jansen, ... Modern Pathology 29 (9), 1028-1037, 2016 | 109 | 2016 |
| DNA repair genes are selectively mutated in diffuse large B cell lymphomas NFCC de Miranda, R Peng, K Georgiou, C Wu, EF Sörqvist, M Berglund, ... Journal of Experimental Medicine 210 (9), 1729-1742, 2013 | 105 | 2013 |
| Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients B Kenkhuis, A Somarakis, L de Haan, O Dzyubachyk, ME IJsselsteijn, ... Acta neuropathologica communications 9, 1-15, 2021 | 98 | 2021 |
| DNA repair: the link between primary immunodeficiency and cancer NFCC de Miranda, A Björkman, Q Pan‐Hammarström Annals of the New York Academy of Sciences 1246 (1), 50-63, 2011 | 97 | 2011 |
| γδ T cells are effectors of immunotherapy in cancers with HLA class I defects NL de Vries, J van de Haar, V Veninga, M Chalabi, ME Ijsselsteijn, ... Nature 613 (7945), 743-750, 2023 | 94 | 2023 |
Marieke E. IjsselsteijnLeiden University Medical CentreVerified email at lumc.nl
